Leverage Shares 2X Long CRM Daily ETF
CRMG
2 hedge funds and large institutions have $93.5K invested in Leverage Shares 2X Long CRM Daily ETF in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
30% more capital invested
Capital invested by funds: $72K → $93.5K (+$21.5K)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
1.76% less ownership
Funds ownership: 2.4% → 0.64% (-1.8%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $194K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Optiver Holding
Amsterdam,
Netherlands
|
+$58K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$24.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$39K |
CRMG Hedge Fund Activity: Q3 2025 in Review
2 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Leverage Shares 2X Long CRM Daily ETF (CRMG) for Q3 2025, worth a combined $93.5K — up 30% from $72K a quarter earlier.
Fund positioning in CRMG was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Optiver Holding, adding an estimated $58K. The largest seller was UBS Group, exiting entirely with an estimated $39K sold.
- 2 institutional investors held Leverage Shares 2X Long CRM Daily ETF (CRMG) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $93.5K of Leverage Shares 2X Long CRM Daily ETF stock for Q3 2025, up 30% quarter-over-quarter.
- 1 fund opened new Leverage Shares 2X Long CRM Daily ETF positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest Leverage Shares 2X Long CRM Daily ETF buyer in Q3 2025 was Optiver Holding, an estimated $58K added.
- The largest Leverage Shares 2X Long CRM Daily ETF seller in Q3 2025 was UBS Group, an estimated $39K sold.
Based on aggregated 13F filings for Q3 2025.